Article info
PDFReview
Drug induced myopathies
- Correspondence to: F L Mastaglia, Director, Centre for Neuromuscular and Neurological Disorders, Australian Neuromuscular Research Institute, Queen Elizabeth II Medical Centre, Nedlands, Western Australia; flmast{at}cyllene.uwa.edu.au
Citation
Drug induced myopathies
Publication history
- First published February 8, 2006.
Online issue publication
April 14, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 Journal of Neurology Neurosurgery and Psychiatry
Other content recommended for you
- Toxic and drug-induced myopathies
- Proximal myopathy: diagnostic approach and initial management
- Muscle disease
- Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study
- Muscle biopsy: what and why and when?
- Severe rhabdomyolysis associated with a primary cytomegalovirus infection in an immunocompetent patient
- Statin induced myopathy
- Statin-related myopathies
- Persisting weakness after withdrawal of a statin
- Colchicine-induced rhabdomyolysis: a review of 83 cases